State Of Alaska, Department Of Revenue Gilead Sciences, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $8.95 Billion
- Q4 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 180,407 shares of GILD stock, worth $19.9 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
180,407
Previous 205,571
12.24%
Holding current value
$19.9 Million
Previous $17.2 Million
3.31%
% of portfolio
0.19%
Previous 0.18%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
2,091Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.8 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.92 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.67 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.4 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...